Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disorder that is principally characterized by hemolytic anemia, (usually rather mild), however, the presence of neurological symptoms has also been reported.
Features include always present findings: Reduced erythrocyte gamma-glutamyl cysteine synthetase activity, Red blood cell destruction (hemolytic anemia), Increased immature red blood cells (reticulocytosis), and Elevated LDH (tissue damage marker) (increased circulating lactate dehydrogenase concentration). 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | Red blood cell destruction (hemolytic anemia), Increased immature red blood cells (reticulocytosis) |
Muscles | 1 | Myopathy |
Brain and nerves | 1 | Polyneuropathy |
Lab test results | 1 | Elevated LDH (tissue damage marker) (increased circulating lactate dehydrogenase concentration) |
Kidneys and urinary system | 1 | Elevated urinary gamma-glutamylcysteine level |
GCLC encodes glutamate-cysteine ligase catalytic subunit (637 aa). Catalyzes the ATP-dependent ligation of L-glutamate and L-cysteine and participates in the first and rate-limiting step in glutathione biosynthesis Highest expression in Bladder (33.0 TPM) and Spleen (27.6 TPM).
Gamma-glutamylcysteine synthetase deficiency is associated with mutations in the GCLC gene on chromosome 6.
The GCLC protein participates in Response to metal ions pathway.
GCLC is classified as a druggable target (Druggable Genome and Enzyme categories) with score 2.6.
Gamma-glutamylcysteine synthetase deficiency is included in newborn screening programs (Galactokinase Deficiency) in 11 states.
Genetic testing for GCLC is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for gamma-glutamylcysteine synthetase deficiency.
10 publications have been identified in PubMed for gamma-glutamylcysteine synthetase deficiency. Research spans Basic Science / Preclinical (40%), Case Report / Case Series (20%), and Clinical Trial Publication (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 4 | 40% |
Patient case studies | 2 | 20% |
Clinical study results | 2 | 20% |
Disease patterns and progression | 2 | 20% |
He J (2025). [PMID: 39859401](https://pubmed.ncbi.nlm.nih.gov/39859401/). *Int J Mol Sci*. [Basic Science / Preclinical]
Naamansen AB (2025). [PMID: 39651840](https://pubmed.ncbi.nlm.nih.gov/39651840/). *American journal of hematology*. [Epidemiology / Natural History]
Ma TY (2025). [PMID: 41463922](https://pubmed.ncbi.nlm.nih.gov/41463922/). *Animals : an open access journal from MDPI*. [Case Report / Case Series]
Haimi M (2025). [PMID: 40277844](https://pubmed.ncbi.nlm.nih.gov/40277844/). *Hematology reports*. [Case Report / Case Series]
Kuo KHM (2024). [PMID: 38712615](https://pubmed.ncbi.nlm.nih.gov/38712615/). *American journal of hematology*. [Clinical Trial Publication]
O'Shaughnessy S (2024). [PMID: 39544255](https://pubmed.ncbi.nlm.nih.gov/39544255/). *Immunometabolism (Cobham)*. [Basic Science / Preclinical]
Glenthøj A (2024). [PMID: 39118415](https://pubmed.ncbi.nlm.nih.gov/39118415/). *British journal of haematology*. [Epidemiology / Natural History]
Glenthøj A (2024). [PMID: 39079928](https://pubmed.ncbi.nlm.nih.gov/39079928/). *BMJ open*. [Clinical Trial Publication]
Al-Hatou M (2024). [PMID: 39359943](https://pubmed.ncbi.nlm.nih.gov/39359943/). *Molecular syndromology*. [Basic Science / Preclinical]
Bartnik M (2024). [PMID: 39766843](https://pubmed.ncbi.nlm.nih.gov/39766843/). *Genes*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center